DNA vaccine pVAX1-SRS13 protects against chronic toxoplasmosis in vivo
Oct. 3, 2024
Ege University scientists and their collaborators have detailed the preclinical characterization of a novel DNA vaccine encoding the SRS13 protein being developed for the prevention of chronic toxoplasmosis.